Search
Feed aggregator
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing 5/24/2024
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial 5/24/2024
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial 5/24/2024
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study 5/24/2024
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far? 5/24/2024
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024
Takeda Joins Hot Molecular Glue Market With $1.2B Deal
Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024
Do You Need to Love Your Job to Be Happy at Your Job?
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target